Cytora Therapeutics Ltd.
PrivateCompany Overview
Cytora Therapeutics Ltd. operates in Healthcare & Life Sciences and is based in Israel. It was founded in 2018.
Cytora Therapeutics Ltd. is a biotechnology company that develops allogeneic, off-the-shelf stem cell therapies derived from human oral mucosa stem cells for the treatment of chronic wounds and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytora Therapeutics Ltd. Comparables
Compare Cytora Therapeutics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stempeutics Research | 78% | |
| RHEACELL GmbH & Co. KG | 76% | |
| BL Pharmtech Corp. | 72% |
For institutional investors. Book with your work email.
Cytora Therapeutics Ltd. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cytora Therapeutics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed, Grant |
| Tadmor Group | Seed |
Cytora Therapeutics Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytora Therapeutics Ltd.'s valuation, stock price, and market status.
Is Cytora Therapeutics Ltd. a public or private company?
Cytora Therapeutics Ltd. is a private company.
What is the current stock price of Cytora Therapeutics Ltd.?
Cytora Therapeutics Ltd. is a private company, so its shares have no public market price. Caplight tracks Cytora Therapeutics Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytora Therapeutics Ltd. worth (valuation)?
Valuation information for Cytora Therapeutics Ltd. is not publicly available.
Can I buy Cytora Therapeutics Ltd. stock?
Cytora Therapeutics Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytora Therapeutics Ltd.'s last funding round?
Funding round information for Cytora Therapeutics Ltd. is not publicly available.
Who are the main investors in Cytora Therapeutics Ltd.?
Key investors in Cytora Therapeutics Ltd. include Israel Innovation Authority, Tadmor Group.
Will Cytora Therapeutics Ltd. IPO soon?
No public IPO plans have been announced for Cytora Therapeutics Ltd..
How can I track Cytora Therapeutics Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Cytora Therapeutics Ltd.'s shares on secondary markets.